Identify new markers for cancer with qPCR

Identify new markers for cancer with qPCR

December 20, 2016

One of the most exciting potential applications of circulating non-coding RNAs like microRNA (miRNA) and long non-coding RNA (lncRNA) is as biomarkers for early detection of cancer. Easily accessible markers like RNAs in the blood are an attractive possibility for finding cancers as soon as possible. Our scientists have compiled an application note showing how to use qPCR in translational research to identify potential lncRNA biomarkers in lung cancer. Check it out here!

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us